A detailed history of Qube Research & Technologies LTD transactions in Dexcom Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 236,001 shares of DXCM stock, worth $17.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
236,001
Previous 9,606 2356.81%
Holding current value
$17.5 Million
Previous $1.33 Million 1908.78%
% of portfolio
0.04%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $25 Million - $31.8 Million
226,395 Added 2356.81%
236,001 $26.8 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $142,432 - $174,704
1,247 Added 14.92%
9,606 $1.33 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $33.1 Million - $54.4 Million
-437,893 Reduced 98.13%
8,359 $1.04 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $28.5 Million - $45.8 Million
331,708 Added 289.59%
446,252 $41.6 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $11.4 Million - $13.2 Million
-101,030 Reduced 46.87%
114,544 $14.7 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $22.4 Million - $26.5 Million
215,574 New
215,574 $25 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $20.2 Million - $39.5 Million
297,382 New
297,382 $22.2 Million
Q1 2022

May 09, 2022

SELL
$94.08 - $130.2 $2.11 Million - $2.92 Million
-22,457 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$129.87 - $162.82 $2.92 Million - $3.66 Million
22,457 New
22,457 $12.1 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $2.19 Million - $2.94 Million
-28,131 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $1.81 Million - $2.13 Million
-18,900 Reduced 40.19%
28,131 $11.6 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $2.95 Million - $4.95 Million
47,031 New
47,031 $19.1 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.